Cargando…

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)

Objective Our studies aimed to evaluate in clinical trials the safety and immunogenicity of an H5 live influenza vaccine candidate obtained using classical reassortment techniques from a low pathogenicity avian influenza (LPAI) A/Duck/Potsdam/1402‐6/86(H5N2) virus and the cold‐adapted (ca) donor st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudenko, Larisa, Desheva, Julia, Korovkin, Sergey, Mironov, Alexander, Rekstin, Andrey, Grigorieva, Elena, Donina, Svetlana, Gambaryan, Alexandra, Katlinsky, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634119/ https://www.ncbi.nlm.nih.gov/pubmed/19453396 http://dx.doi.org/10.1111/j.1750-2659.2008.00064.x

Ejemplares similares

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
por: Rekstin, Andrey, et al.
Publicado: (2014)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
por: Rekstin, Andrey, et al.
Publicado: (2017)

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model
por: Rudenko, Larisa, et al.
Publicado: (2018)

B‐ and T‐cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus‐specific memory T‐cells using trogocytosis‐based method
por: Petukhova, Galina, et al.
Publicado: (2011)

Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
por: Rudenko, Larisa, et al.
Publicado: (2018)

Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge
por: Mezhenskaya, Daria, et al.
Publicado: (2021)

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
por: Isakova-Sivak, Irina, et al.
Publicado: (2019)

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
por: Kiseleva, Irina, et al.
Publicado: (2018)

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
por: Desheva, Yulia A, et al.
Publicado: (2015)

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses
por: Shcherbik, Svetlana, et al.
Publicado: (2015)

Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza
por: Kiseleva, Irina, et al.
Publicado: (2017)

Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
por: Desheva, Yulia, et al.
Publicado: (2022)

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
por: Rudenko, Larisa, et al.
Publicado: (2015)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine
por: Rudenko, Larisa, et al.
Publicado: (2014)

Rapid Strategy for Screening by Pyrosequencing of Influenza Virus Reassortants - Candidates for Live Attenuated Vaccines
por: Shcherbik, Svetlana V., et al.
Publicado: (2014)

Contribution of Neuraminidase of Influenza Viruses to the Sensitivity to Sera Inhibitors and Reassortment Efficiency
por: Kiseleva, Irina, et al.
Publicado: (2014)

Assessment of trivalent live influenza vaccines in MDCK cell line
por: Landgraf, G., et al.
Publicado: (2021)

Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection
por: Desheva, Yulia A., et al.
Publicado: (2019)

Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice
por: Kramskaya, T., et al.
Publicado: (2019)

Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model
por: Stepanova, Ekaterina, et al.
Publicado: (2021)

Comparative safety, immunogenicity, and efficacy of several anti‐H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine)
por: Gambaryan, Alexandra S., et al.
Publicado: (2011)

A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults
por: Kiseleva, Irina, et al.
Publicado: (2020)

Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research
por: Kiseleva, Irina, et al.
Publicado: (2020)

Diversity and Reassortment Rate of Influenza A Viruses in Wild Ducks and Gulls
por: Postnikova, Yulia, et al.
Publicado: (2021)

Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests
por: Rak, Alexandra, et al.
Publicado: (2022)

Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years
por: Desheva, Yulia, et al.
Publicado: (2022)

Corrigendum to “Assessment of trivalent live influenza vaccines in MDCK cell line” [MethodsX 8 (2021) 101442]
por: Landgraf, G., et al.
Publicado: (2021)

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals
por: Desheva, Yulia, et al.
Publicado: (2018)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories
por: Rudenko, Larisa, et al.
Publicado: (2016)

Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine
por: Matyushenko, Victoria, et al.
Publicado: (2017)

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu
por: Nechaeva, Elena A, et al.
Publicado: (2015)

Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A, et al.
Publicado: (2017)

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A., et al.
Publicado: (2016)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

Reassortment Patterns in Swine Influenza Viruses
por: Khiabanian, Hossein, et al.
Publicado: (2009)

Predicting Hotspots for Influenza Virus Reassortment
por: Fuller, Trevon L., et al.
Publicado: (2013)

Fitness cost of reassortment in human influenza
por: Villa, Mara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_po76e1duociu0mt4jh0m24s14r